Vulnerability · Published May 22, 2023 · Assigned by mitre
CVE-2023-31923
High 8.8
In plain English
A high-severity security flaw in the affected software. Proof-of-concept exploit code is public. The chance it is exploited in the next 30 days is estimated at 0.9% (higher than 59% of all known vulnerabilities).
Severity (CVSS NVD)8.8High
Exploit odds (30 days)0.9%top 41.2% of all CVEs
Exploited in the wildNo reportsCISA SSVC: poc
Attack toolingNoneno public tooling known
Official description
Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.